SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor

Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. DFP was found to be a potent and highly selectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 1999-08, Vol.9 (15), p.2207-2212
Hauptverfasser: Leblanc, Y., Roy, P., Boyce, S., Brideau, C., Chan, C.C., Charleson, S., Gordon, R., Grimm, E., Guay, J., Léger, S., Li, C.S., Riendeau, D., Visco, D., Wang, Z., Webb, J., Xu, L.J., Prasit, P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2212
container_issue 15
container_start_page 2207
container_title Bioorganic & medicinal chemistry letters
container_volume 9
creator Leblanc, Y.
Roy, P.
Boyce, S.
Brideau, C.
Chan, C.C.
Charleson, S.
Gordon, R.
Grimm, E.
Guay, J.
Léger, S.
Li, C.S.
Riendeau, D.
Visco, D.
Wang, Z.
Webb, J.
Xu, L.J.
Prasit, P.
description Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. DFP was found to be a potent and highly selective COX-2 inhibitor.
doi_str_mv 10.1016/S0960-894X(99)00365-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69992598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X99003650</els_id><sourcerecordid>69992598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-bc8f53c3251752fa0b876fce227f84312cb4d586e67bf8427e03294e8ec2fade3</originalsourceid><addsrcrecordid>eNqFkN9LHDEQx0Ox6NX6Jyh5KKVCt51kk-zGlyJXf4FgqRV8C9nsLKbd25zJ3tH77xvvDuubTwMzn-_M8CHkkMEXBkx9vQWtoKi1uP-k9TFAqWQBb8iECSWKUoDcIZNnZI-8S-k3ABMgxC7ZYyCUlKKakOb29Cf1Ax0fkNr-T_i7or11YxiQJowe08l61PrkwhLjioaOfj__8ZlaOg8jDiO1Q0tDtH2_ojnol0inN_cFz0sffOPHEN-Tt53tEx5s6z65Oz_7Nb0srm8urqan14UrNYxF4-pOlq7kklWSdxaaulKdQ86rrhYl464RrawVqqrJDV4hlFwLrNFlusVyn3zc7J3H8LjANJpZ_hr73g4YFskorTWXus6g3IAuhpQidmYe_czGlWFgnuSatVzzZM5obdZyDeTc0fbAoplh-yK1sZmBD1vAJmf7LtrB-fSf00zoSmbs2wbDbGPpMZrkPA4OWx_RjaYN_pVP_gHKtZWN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69992598</pqid></control><display><type>article</type><title>SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Leblanc, Y. ; Roy, P. ; Boyce, S. ; Brideau, C. ; Chan, C.C. ; Charleson, S. ; Gordon, R. ; Grimm, E. ; Guay, J. ; Léger, S. ; Li, C.S. ; Riendeau, D. ; Visco, D. ; Wang, Z. ; Webb, J. ; Xu, L.J. ; Prasit, P.</creator><creatorcontrib>Leblanc, Y. ; Roy, P. ; Boyce, S. ; Brideau, C. ; Chan, C.C. ; Charleson, S. ; Gordon, R. ; Grimm, E. ; Guay, J. ; Léger, S. ; Li, C.S. ; Riendeau, D. ; Visco, D. ; Wang, Z. ; Webb, J. ; Xu, L.J. ; Prasit, P.</creatorcontrib><description>Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. DFP was found to be a potent and highly selective COX-2 inhibitor.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(99)00365-0</identifier><identifier>PMID: 10465547</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Administration, Oral ; Animals ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cyclooxygenase 2 ; Cyclooxygenase 2 Inhibitors ; Cyclooxygenase Inhibitors - chemical synthesis ; Cyclooxygenase Inhibitors - chemistry ; Cyclooxygenase Inhibitors - pharmacokinetics ; Cyclooxygenase Inhibitors - pharmacology ; Humans ; Isoenzymes - drug effects ; Isoenzymes - metabolism ; Macaca mulatta ; Medical sciences ; Membrane Proteins ; Pharmacology. Drug treatments ; Prostaglandin-Endoperoxide Synthases - drug effects ; Prostaglandin-Endoperoxide Synthases - metabolism ; Rats ; Saimiri ; Structure-Activity Relationship ; U937 Cells</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 1999-08, Vol.9 (15), p.2207-2212</ispartof><rights>1999</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-bc8f53c3251752fa0b876fce227f84312cb4d586e67bf8427e03294e8ec2fade3</citedby><cites>FETCH-LOGICAL-c390t-bc8f53c3251752fa0b876fce227f84312cb4d586e67bf8427e03294e8ec2fade3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X99003650$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1914975$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10465547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leblanc, Y.</creatorcontrib><creatorcontrib>Roy, P.</creatorcontrib><creatorcontrib>Boyce, S.</creatorcontrib><creatorcontrib>Brideau, C.</creatorcontrib><creatorcontrib>Chan, C.C.</creatorcontrib><creatorcontrib>Charleson, S.</creatorcontrib><creatorcontrib>Gordon, R.</creatorcontrib><creatorcontrib>Grimm, E.</creatorcontrib><creatorcontrib>Guay, J.</creatorcontrib><creatorcontrib>Léger, S.</creatorcontrib><creatorcontrib>Li, C.S.</creatorcontrib><creatorcontrib>Riendeau, D.</creatorcontrib><creatorcontrib>Visco, D.</creatorcontrib><creatorcontrib>Wang, Z.</creatorcontrib><creatorcontrib>Webb, J.</creatorcontrib><creatorcontrib>Xu, L.J.</creatorcontrib><creatorcontrib>Prasit, P.</creatorcontrib><title>SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. DFP was found to be a potent and highly selective COX-2 inhibitor.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cyclooxygenase 2</subject><subject>Cyclooxygenase 2 Inhibitors</subject><subject>Cyclooxygenase Inhibitors - chemical synthesis</subject><subject>Cyclooxygenase Inhibitors - chemistry</subject><subject>Cyclooxygenase Inhibitors - pharmacokinetics</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Isoenzymes - drug effects</subject><subject>Isoenzymes - metabolism</subject><subject>Macaca mulatta</subject><subject>Medical sciences</subject><subject>Membrane Proteins</subject><subject>Pharmacology. Drug treatments</subject><subject>Prostaglandin-Endoperoxide Synthases - drug effects</subject><subject>Prostaglandin-Endoperoxide Synthases - metabolism</subject><subject>Rats</subject><subject>Saimiri</subject><subject>Structure-Activity Relationship</subject><subject>U937 Cells</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN9LHDEQx0Ox6NX6Jyh5KKVCt51kk-zGlyJXf4FgqRV8C9nsLKbd25zJ3tH77xvvDuubTwMzn-_M8CHkkMEXBkx9vQWtoKi1uP-k9TFAqWQBb8iECSWKUoDcIZNnZI-8S-k3ABMgxC7ZYyCUlKKakOb29Cf1Ax0fkNr-T_i7or11YxiQJowe08l61PrkwhLjioaOfj__8ZlaOg8jDiO1Q0tDtH2_ojnol0inN_cFz0sffOPHEN-Tt53tEx5s6z65Oz_7Nb0srm8urqan14UrNYxF4-pOlq7kklWSdxaaulKdQ86rrhYl464RrawVqqrJDV4hlFwLrNFlusVyn3zc7J3H8LjANJpZ_hr73g4YFskorTWXus6g3IAuhpQidmYe_czGlWFgnuSatVzzZM5obdZyDeTc0fbAoplh-yK1sZmBD1vAJmf7LtrB-fSf00zoSmbs2wbDbGPpMZrkPA4OWx_RjaYN_pVP_gHKtZWN</recordid><startdate>19990802</startdate><enddate>19990802</enddate><creator>Leblanc, Y.</creator><creator>Roy, P.</creator><creator>Boyce, S.</creator><creator>Brideau, C.</creator><creator>Chan, C.C.</creator><creator>Charleson, S.</creator><creator>Gordon, R.</creator><creator>Grimm, E.</creator><creator>Guay, J.</creator><creator>Léger, S.</creator><creator>Li, C.S.</creator><creator>Riendeau, D.</creator><creator>Visco, D.</creator><creator>Wang, Z.</creator><creator>Webb, J.</creator><creator>Xu, L.J.</creator><creator>Prasit, P.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990802</creationdate><title>SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor</title><author>Leblanc, Y. ; Roy, P. ; Boyce, S. ; Brideau, C. ; Chan, C.C. ; Charleson, S. ; Gordon, R. ; Grimm, E. ; Guay, J. ; Léger, S. ; Li, C.S. ; Riendeau, D. ; Visco, D. ; Wang, Z. ; Webb, J. ; Xu, L.J. ; Prasit, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-bc8f53c3251752fa0b876fce227f84312cb4d586e67bf8427e03294e8ec2fade3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cyclooxygenase 2</topic><topic>Cyclooxygenase 2 Inhibitors</topic><topic>Cyclooxygenase Inhibitors - chemical synthesis</topic><topic>Cyclooxygenase Inhibitors - chemistry</topic><topic>Cyclooxygenase Inhibitors - pharmacokinetics</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Isoenzymes - drug effects</topic><topic>Isoenzymes - metabolism</topic><topic>Macaca mulatta</topic><topic>Medical sciences</topic><topic>Membrane Proteins</topic><topic>Pharmacology. Drug treatments</topic><topic>Prostaglandin-Endoperoxide Synthases - drug effects</topic><topic>Prostaglandin-Endoperoxide Synthases - metabolism</topic><topic>Rats</topic><topic>Saimiri</topic><topic>Structure-Activity Relationship</topic><topic>U937 Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leblanc, Y.</creatorcontrib><creatorcontrib>Roy, P.</creatorcontrib><creatorcontrib>Boyce, S.</creatorcontrib><creatorcontrib>Brideau, C.</creatorcontrib><creatorcontrib>Chan, C.C.</creatorcontrib><creatorcontrib>Charleson, S.</creatorcontrib><creatorcontrib>Gordon, R.</creatorcontrib><creatorcontrib>Grimm, E.</creatorcontrib><creatorcontrib>Guay, J.</creatorcontrib><creatorcontrib>Léger, S.</creatorcontrib><creatorcontrib>Li, C.S.</creatorcontrib><creatorcontrib>Riendeau, D.</creatorcontrib><creatorcontrib>Visco, D.</creatorcontrib><creatorcontrib>Wang, Z.</creatorcontrib><creatorcontrib>Webb, J.</creatorcontrib><creatorcontrib>Xu, L.J.</creatorcontrib><creatorcontrib>Prasit, P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leblanc, Y.</au><au>Roy, P.</au><au>Boyce, S.</au><au>Brideau, C.</au><au>Chan, C.C.</au><au>Charleson, S.</au><au>Gordon, R.</au><au>Grimm, E.</au><au>Guay, J.</au><au>Léger, S.</au><au>Li, C.S.</au><au>Riendeau, D.</au><au>Visco, D.</au><au>Wang, Z.</au><au>Webb, J.</au><au>Xu, L.J.</au><au>Prasit, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>1999-08-02</date><risdate>1999</risdate><volume>9</volume><issue>15</issue><spage>2207</spage><epage>2212</epage><pages>2207-2212</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. DFP was found to be a potent and highly selective COX-2 inhibitor.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>10465547</pmid><doi>10.1016/S0960-894X(99)00365-0</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 1999-08, Vol.9 (15), p.2207-2212
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_69992598
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Administration, Oral
Animals
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors - chemical synthesis
Cyclooxygenase Inhibitors - chemistry
Cyclooxygenase Inhibitors - pharmacokinetics
Cyclooxygenase Inhibitors - pharmacology
Humans
Isoenzymes - drug effects
Isoenzymes - metabolism
Macaca mulatta
Medical sciences
Membrane Proteins
Pharmacology. Drug treatments
Prostaglandin-Endoperoxide Synthases - drug effects
Prostaglandin-Endoperoxide Synthases - metabolism
Rats
Saimiri
Structure-Activity Relationship
U937 Cells
title SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A42%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SAR%20in%20the%20alkoxy%20lactone%20series:%20the%20discovery%20of%20DFP,%20a%20potent%20and%20orally%20active%20COX-2%20inhibitor&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Leblanc,%20Y.&rft.date=1999-08-02&rft.volume=9&rft.issue=15&rft.spage=2207&rft.epage=2212&rft.pages=2207-2212&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(99)00365-0&rft_dat=%3Cproquest_cross%3E69992598%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69992598&rft_id=info:pmid/10465547&rft_els_id=S0960894X99003650&rfr_iscdi=true